Banyan Gold Corp. (TSXV:BYN)

Sage Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	22.4	13.79	8.15	11.61	14.36	5.36
Cash & Short-Term Investments	22.4	13.79	8.15	11.61	14.36	5.36
Cash Growth	316.50%	69.21%	-29.81%	-19.13%	168.13%	1473.68%
Other Receivables	0.11	0.38	0.46	0.81	0.31	0.09
Receivables	0.11	0.38	0.46	0.81	0.31	0.09
Prepaid Expenses	0.55	0.04	0.03	0.03	0.06	0.05
Total Current Assets	23.06	14.22	8.63	12.45	14.73	5.5
Property, Plant & Equipment	61.4	58.41	49.73	35.88	17.29	7.95
Other Long-Term Assets	0.15	0.15	0.14	0.04	-	-
Total Assets	84.62	72.77	58.5	48.36	32.02	13.45
Accounts Payable	0.5	2.15	0.77	1.74	0.97	0.76
Other Current Liabilities	-	0.06	0.01	0.08	0.1	0.07
Total Current Liabilities	13.62	15.32	9.54	10.55	7.57	0.82
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.54
Total Liabilities	13.62	15.32	9.54	10.55	7.57	2.37
Common Stock	80.36	65.85	54.62	44.51	30.24	14.54
Additional Paid-In Capital	4.57	4.27	2.74	2.07	1.52	0.93
Retained Earnings	-13.93	-12.68	-8.4	-8.76	-7.31	-4.39
Comprehensive Income & Other	-	-	-	0	-	-
Shareholders' Equity	71	57.44	48.96	37.81	24.45	11.08
Total Liabilities & Equity	84.62	72.77	58.5	48.36	32.02	13.45
Net Cash (Debt)	22.4	13.79	8.15	11.61	14.36	5.36
Net Cash Growth	316.50%	69.21%	-29.81%	-19.13%	168.13%	1473.68%
Net Cash Per Share	0.07	0.05	0.03	0.05	0.08	0.04
Filing Date Shares Outstanding	375.98	328.79	284.87	259.22	226.17	161.76
Total Common Shares Outstanding	375.98	328.79	284.87	259.22	226.17	161.76
Working Capital	9.44	-1.11	-0.91	1.89	7.16	4.67
Book Value Per Share	0.19	0.17	0.17	0.15	0.11	0.07
Tangible Book Value	71	57.44	48.96	37.81	24.45	11.08
Tangible Book Value Per Share	0.19	0.17	0.17	0.15	0.11	0.07
Buildings	0.29	0.29	0.29	0.29	0.29	-
Machinery	0.78	0.72	0.7	0.56	0.24	0.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.